UnitedHealth aids Mayo Clinic’s COVID-19 plasma study

A COVID-19 plasma treatment study led by Rochester, Minn.-based Mayo Clinic will get funding from UnitedHealth Group to help accelerate the federally sponsored program.

Advertisement

The clinical initiative aims to coordinate blood plasma collection from recently recovered COVID-19 patients and use the plasma to treat hospital patients with severe COVID-19 infections. 

Mayo Clinic is coordinating efforts across 1,600-plus sites nationwide. So far, more than 600 patients have received convalescent plasma treatment. 

UnitedHealth’s $5 million donation to the effort brings its COVID-19 donations up to $70 million to date. 

More articles on payers:
UnitedHealth posts $3.4B profit; Optum CEO to take leave of absence
UnitedHealth considers rebates as claims costs for elective surgeries fall
900 furloughed MUSC employees to get insurance paid for by donations

Advertisement

Next Up in Payer

Advertisement

Comments are closed.